# Lung Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/lung-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 83.4 |
| Citations | 2,680,321 |
| City | Dallas |
| Country | US |
| Description | Lung Institute is a research organisation in Dallas, US. OpenAlex records 16,268 works and 2,680,321 citations for it. 3,062 researchers list it as their most recent affiliation. |
| Homepage | https://lunginstitute.com/ |
| OpenAlex ID | https://openalex.org/I4210101049 |
| Region | Texas |
| Researchers | 3,062 |
| ROR ID | https://ror.org/016978714 |
| Type | healthcare |
| Works | 16,268 |

## University papers

Showing 12 of 39.

- [Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease](https://scholariq.org/papers/evolocumab-and-clinical-outcomes-in-patients-with-cardiovascular-disease/)
- [Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial](https://scholariq.org/papers/prevention-of-coronary-and-stroke-events-with-atorvastatin-in-hypertensive/)
- [Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-cardiovascular-outcomes-in-type-2-diabetes-rewind-a-double-blind/)
- [Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial](https://scholariq.org/papers/prevention-of-cardiovascular-events-with-an-antihypertensive-regimen-of/)
- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research](https://scholariq.org/papers/per-and-polyfluoroalkyl-substance-toxicity-and-human-health-review-current-state/)
- [Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study](https://scholariq.org/papers/modifiable-risk-factors-cardiovascular-disease-and-mortality-in-155-722/)
- [Interpretation of the evidence for the efficacy and safety of statin therapy](https://scholariq.org/papers/interpretation-of-the-evidence-for-the-efficacy-and-safety-of-statin-therapy/)
- [Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension](https://scholariq.org/papers/prognostic-significance-of-visit-to-visit-variability-maximum-systolic-blood/)
- [Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.](https://scholariq.org/papers/selectivity-of-nonsteroidal-antiinflammatory-drugs-as-inhibitors-of-constitutive/)
- [Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial](https://scholariq.org/papers/spironolactone-versus-placebo-bisoprolol-and-doxazosin-to-determine-the-optimal/)
- [Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study](https://scholariq.org/papers/associations-of-fats-and-carbohydrate-intake-with-cardiovascular-disease-and/)

## University top topics

Showing 8 of 25.

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.